Fever Tree is a founder-led beverage business that sells premium mixers such as tonics, ginger ale, and club soda.
Over the last decade, two tailwinds have fuelled FEVR's ~50% revenue CAGR: premiumisation and spirits winning share from beer and wine. The company defined the UK premium mixer category which accounted for 43% of all mixers in H121. In the US, the premium segment is only 10% but is growing at ~3x the total mixer market.
In 2018, the company launched a national distribution agreement with Southern Glazers, the largest spirits distributor in the US. Fever Tree focused on building the brand equity with premium spirits companies in the on-premise channel and has the longest and deepest relationships with companies like Diageo and Pernod.
Fever Tree is a beverage company that operates closer to a premium spirits business with 30%+ ROE, deep distribution agreements and high brand equity in both channels that provide high barriers to entry for competitors.
Over the last decade, two structural trends have been shaping the global spirits industry:
From 2014-19, the global spirits volume CAGR was 1% compared to 0.2% for wine and negative 0.4% for beer. After 3-4% price increases per year, the total spirits market value grows ~5% per year but the premium and super-premium segments are growing 11% and 8% respectively. From 2010-20, the US premium category has grown from 19% to 27% of total volume. We could still be in the early innings of the spirits premiumisation trend.
The premiumisation of spirits has gone hand in hand with the premiumisation of mixers. Over the last 3 years, the premium mixer category has grown 31% and 15% per year in the US and UK respectively. However, the big difference is the penetration level: in the US, the premium category is only 10% of total mixer value versus over 40% in the UK. This growth opportunity is what interested us about Fever Tree; if the premiumisation trend continues, there is a potential multi-decade growth opportunity ahead.
We interviewed a Former VP of Sales at Q-Mixers, Fever Tree’s largest premium competitor, to discuss how the brands competed in the US on-premise channel.
Although both Q and Fever Tree serve the premium mixer segment, there is one fundamental difference between the two companies: Q was built in the off-premise channel whereas Fever Tree was built on-premise. This is important because the go-to-market distribution channel shapes the DNA of a consumer brand. Q’s founder got his first break when he sold a pallet of mixers directly to Whole Foods and built a direct sales team to serve the large grocery chains and independents across the US. From the start, Q’s product was optimised for the retail channel:
"Going to that channel first was more about creating a package and a size that made sense for retail first. In on-premise, the outer package is less important and, in retail, it was about single-serving size to the individual consumer who was making their own cocktail at home...In a retail environment, your product is your sales person. There is nothing else in the store, selling your brand. Your package has to deliver on its messaging, the story and convenience. It’s critically important in retail to make sure you have got your package, your pricing and your messaging on your bottle or your outer package right. It’s very hard to go to off-premise first and then to on-premise." - Former VP of Sales, Q-Mixers
On the other hand, Fever Tree was built with bartenders in the on-premise channel. The company has a national agreement with Southern Glazers, the largest spirits distributor in the US, and partners with large spirit companies such as Diageo and Pernod Ricard. Fever Tree has focused on winning the hearts of mixologists to provide the best drinking experience in clubs and bars globally.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities.
© 2024 IP 1 Ltd. All rights reserved.
Subscribe to access hundreds of interviews and primary research